nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.189	0.356	CbGbCtD
Magnesium salicylate—PTGS2—Etoposide—peripheral nervous system neoplasm	0.185	0.349	CbGbCtD
Magnesium salicylate—PTGS1—Etoposide—peripheral nervous system neoplasm	0.157	0.295	CbGbCtD
Magnesium salicylate—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00151	0.00322	CcSEcCtD
Magnesium salicylate—Burning sensation—Doxorubicin—peripheral nervous system neoplasm	0.00147	0.00312	CcSEcCtD
Magnesium salicylate—Erythema—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00309	CcSEcCtD
Magnesium salicylate—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00309	CcSEcCtD
Magnesium salicylate—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00306	CcSEcCtD
Magnesium salicylate—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.003	CcSEcCtD
Magnesium salicylate—Hepatitis—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.0029	CcSEcCtD
Magnesium salicylate—Stinging—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00289	CcSEcCtD
Magnesium salicylate—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00287	CcSEcCtD
Magnesium salicylate—Epistaxis—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00283	CcSEcCtD
Magnesium salicylate—Sweating—Vincristine—peripheral nervous system neoplasm	0.0013	0.00277	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00275	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Dactinomycin—peripheral nervous system neoplasm	0.00129	0.00274	CcSEcCtD
Magnesium salicylate—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00126	0.00269	CcSEcCtD
Magnesium salicylate—Hepatitis—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00269	CcSEcCtD
Magnesium salicylate—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00268	CcSEcCtD
Magnesium salicylate—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00268	CcSEcCtD
Magnesium salicylate—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00121	0.00258	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00256	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Alitretinoin—peripheral nervous system neoplasm	0.00119	0.00254	CcSEcCtD
Magnesium salicylate—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00119	0.00254	CcSEcCtD
Magnesium salicylate—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.00254	CcSEcCtD
Magnesium salicylate—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00119	0.00253	CcSEcCtD
Magnesium salicylate—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00252	CcSEcCtD
Magnesium salicylate—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00252	CcSEcCtD
Magnesium salicylate—Tinnitus—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00251	CcSEcCtD
Magnesium salicylate—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.0025	CcSEcCtD
Magnesium salicylate—Oedema—Melphalan—peripheral nervous system neoplasm	0.00117	0.00249	CcSEcCtD
Magnesium salicylate—Shock—Tretinoin—peripheral nervous system neoplasm	0.00116	0.00248	CcSEcCtD
Magnesium salicylate—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00116	0.00248	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00115	0.00246	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00114	0.00244	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00114	0.00244	CcSEcCtD
Magnesium salicylate—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00114	0.00242	CcSEcCtD
Magnesium salicylate—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00113	0.0024	CcSEcCtD
Magnesium salicylate—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.0024	CcSEcCtD
Magnesium salicylate—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00111	0.00237	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00237	CcSEcCtD
Magnesium salicylate—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00111	0.00236	CcSEcCtD
Magnesium salicylate—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00111	0.00236	CcSEcCtD
Magnesium salicylate—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00234	CcSEcCtD
Magnesium salicylate—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00109	0.00233	CcSEcCtD
Magnesium salicylate—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00224	CcSEcCtD
Magnesium salicylate—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00224	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00224	CcSEcCtD
Magnesium salicylate—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00105	0.00224	CcSEcCtD
Magnesium salicylate—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00222	CcSEcCtD
Magnesium salicylate—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00222	CcSEcCtD
Magnesium salicylate—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00104	0.00221	CcSEcCtD
Magnesium salicylate—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00219	CcSEcCtD
Magnesium salicylate—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00219	CcSEcCtD
Magnesium salicylate—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00103	0.00219	CcSEcCtD
Magnesium salicylate—Pain—Topotecan—peripheral nervous system neoplasm	0.00102	0.00217	CcSEcCtD
Magnesium salicylate—Constipation—Topotecan—peripheral nervous system neoplasm	0.00102	0.00217	CcSEcCtD
Magnesium salicylate—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00102	0.00216	CcSEcCtD
Magnesium salicylate—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00216	CcSEcCtD
Magnesium salicylate—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00216	CcSEcCtD
Magnesium salicylate—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00216	CcSEcCtD
Magnesium salicylate—Pain—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00216	CcSEcCtD
Magnesium salicylate—Oesophagitis—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00214	CcSEcCtD
Magnesium salicylate—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.001	0.00214	CcSEcCtD
Magnesium salicylate—Pain—Melphalan—peripheral nervous system neoplasm	0.000999	0.00213	CcSEcCtD
Magnesium salicylate—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000999	0.00213	CcSEcCtD
Magnesium salicylate—Ecchymosis—Epirubicin—peripheral nervous system neoplasm	0.000995	0.00212	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000984	0.0021	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000976	0.00208	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000976	0.00208	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.00207	CcSEcCtD
Magnesium salicylate—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000968	0.00206	CcSEcCtD
Magnesium salicylate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000948	0.00202	CcSEcCtD
Magnesium salicylate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000941	0.002	CcSEcCtD
Magnesium salicylate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000941	0.002	CcSEcCtD
Magnesium salicylate—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000937	0.002	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Etoposide—peripheral nervous system neoplasm	0.000932	0.00199	CcSEcCtD
Magnesium salicylate—Oesophagitis—Doxorubicin—peripheral nervous system neoplasm	0.00093	0.00198	CcSEcCtD
Magnesium salicylate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000928	0.00198	CcSEcCtD
Magnesium salicylate—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000922	0.00197	CcSEcCtD
Magnesium salicylate—Ecchymosis—Doxorubicin—peripheral nervous system neoplasm	0.000921	0.00196	CcSEcCtD
Magnesium salicylate—Flushing—Etoposide—peripheral nervous system neoplasm	0.000915	0.00195	CcSEcCtD
Magnesium salicylate—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000905	0.00193	CcSEcCtD
Magnesium salicylate—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000897	0.00191	CcSEcCtD
Magnesium salicylate—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000883	0.00188	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000867	0.00185	CcSEcCtD
Magnesium salicylate—Oedema—Vincristine—peripheral nervous system neoplasm	0.000865	0.00184	CcSEcCtD
Magnesium salicylate—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000855	0.00182	CcSEcCtD
Magnesium salicylate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000844	0.0018	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000841	0.00179	CcSEcCtD
Magnesium salicylate—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00084	0.00179	CcSEcCtD
Magnesium salicylate—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000838	0.00179	CcSEcCtD
Magnesium salicylate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000838	0.00178	CcSEcCtD
Magnesium salicylate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000838	0.00178	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000836	0.00178	CcSEcCtD
Magnesium salicylate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000828	0.00176	CcSEcCtD
Magnesium salicylate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000827	0.00176	CcSEcCtD
Magnesium salicylate—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000824	0.00176	CcSEcCtD
Magnesium salicylate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000817	0.00174	CcSEcCtD
Magnesium salicylate—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000815	0.00174	CcSEcCtD
Magnesium salicylate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00081	0.00173	CcSEcCtD
Magnesium salicylate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00081	0.00173	CcSEcCtD
Magnesium salicylate—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000808	0.00172	CcSEcCtD
Magnesium salicylate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.0008	0.0017	CcSEcCtD
Magnesium salicylate—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000798	0.0017	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000797	0.0017	CcSEcCtD
Magnesium salicylate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00079	0.00168	CcSEcCtD
Magnesium salicylate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000789	0.00168	CcSEcCtD
Magnesium salicylate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000783	0.00167	CcSEcCtD
Magnesium salicylate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000783	0.00167	CcSEcCtD
Magnesium salicylate—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00078	0.00166	CcSEcCtD
Magnesium salicylate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000767	0.00164	CcSEcCtD
Magnesium salicylate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000767	0.00164	CcSEcCtD
Magnesium salicylate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000765	0.00163	CcSEcCtD
Magnesium salicylate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000759	0.00162	CcSEcCtD
Magnesium salicylate—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000754	0.00161	CcSEcCtD
Magnesium salicylate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000753	0.0016	CcSEcCtD
Magnesium salicylate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000753	0.0016	CcSEcCtD
Magnesium salicylate—Rash—Topotecan—peripheral nervous system neoplasm	0.000753	0.0016	CcSEcCtD
Magnesium salicylate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000752	0.0016	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000752	0.0016	CcSEcCtD
Magnesium salicylate—Headache—Topotecan—peripheral nervous system neoplasm	0.000748	0.00159	CcSEcCtD
Magnesium salicylate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000747	0.00159	CcSEcCtD
Magnesium salicylate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000747	0.00159	CcSEcCtD
Magnesium salicylate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000746	0.00159	CcSEcCtD
Magnesium salicylate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000746	0.00159	CcSEcCtD
Magnesium salicylate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000743	0.00158	CcSEcCtD
Magnesium salicylate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000742	0.00158	CcSEcCtD
Magnesium salicylate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000742	0.00158	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000739	0.00158	CcSEcCtD
Magnesium salicylate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000739	0.00158	CcSEcCtD
Magnesium salicylate—Pain—Vincristine—peripheral nervous system neoplasm	0.000739	0.00158	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000739	0.00157	CcSEcCtD
Magnesium salicylate—Rash—Melphalan—peripheral nervous system neoplasm	0.000737	0.00157	CcSEcCtD
Magnesium salicylate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000736	0.00157	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00073	0.00155	CcSEcCtD
Magnesium salicylate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000729	0.00155	CcSEcCtD
Magnesium salicylate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000714	0.00152	CcSEcCtD
Magnesium salicylate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000713	0.00152	CcSEcCtD
Magnesium salicylate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000709	0.00151	CcSEcCtD
Magnesium salicylate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000706	0.0015	CcSEcCtD
Magnesium salicylate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000703	0.0015	CcSEcCtD
Magnesium salicylate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000703	0.0015	CcSEcCtD
Magnesium salicylate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000694	0.00148	CcSEcCtD
Magnesium salicylate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00069	0.00147	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000677	0.00144	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000675	0.00144	CcSEcCtD
Magnesium salicylate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000668	0.00142	CcSEcCtD
Magnesium salicylate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000665	0.00142	CcSEcCtD
Magnesium salicylate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000662	0.00141	CcSEcCtD
Magnesium salicylate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000654	0.00139	CcSEcCtD
Magnesium salicylate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000654	0.00139	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.00136	CcSEcCtD
Magnesium salicylate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000635	0.00135	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00063	0.00134	CcSEcCtD
Magnesium salicylate—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000628	0.00134	CcSEcCtD
Magnesium salicylate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000623	0.00133	CcSEcCtD
Magnesium salicylate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000616	0.00131	CcSEcCtD
Magnesium salicylate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000615	0.00131	CcSEcCtD
Magnesium salicylate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000614	0.00131	CcSEcCtD
Magnesium salicylate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00061	0.0013	CcSEcCtD
Magnesium salicylate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000609	0.0013	CcSEcCtD
Magnesium salicylate—Pain—Etoposide—peripheral nervous system neoplasm	0.000599	0.00128	CcSEcCtD
Magnesium salicylate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000599	0.00128	CcSEcCtD
Magnesium salicylate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000593	0.00126	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000592	0.00126	CcSEcCtD
Magnesium salicylate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.00059	0.00126	CcSEcCtD
Magnesium salicylate—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.00124	CcSEcCtD
Magnesium salicylate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000581	0.00124	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000577	0.00123	CcSEcCtD
Magnesium salicylate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000575	0.00122	CcSEcCtD
Magnesium salicylate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000572	0.00122	CcSEcCtD
Magnesium salicylate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00057	0.00122	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.00121	CcSEcCtD
Magnesium salicylate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000566	0.00121	CcSEcCtD
Magnesium salicylate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.0012	CcSEcCtD
Magnesium salicylate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000562	0.0012	CcSEcCtD
Magnesium salicylate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000556	0.00119	CcSEcCtD
Magnesium salicylate—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000553	0.00118	CcSEcCtD
Magnesium salicylate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00055	0.00117	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.00116	CcSEcCtD
Magnesium salicylate—Rash—Vincristine—peripheral nervous system neoplasm	0.000545	0.00116	CcSEcCtD
Magnesium salicylate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000545	0.00116	CcSEcCtD
Magnesium salicylate—Headache—Vincristine—peripheral nervous system neoplasm	0.000542	0.00115	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.00114	CcSEcCtD
Magnesium salicylate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000533	0.00114	CcSEcCtD
Magnesium salicylate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000523	0.00111	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000522	0.00111	CcSEcCtD
Magnesium salicylate—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000515	0.0011	CcSEcCtD
Magnesium salicylate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000514	0.00109	CcSEcCtD
Magnesium salicylate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000513	0.00109	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.00109	CcSEcCtD
Magnesium salicylate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000496	0.00106	CcSEcCtD
Magnesium salicylate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000486	0.00104	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000483	0.00103	CcSEcCtD
Magnesium salicylate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000482	0.00103	CcSEcCtD
Magnesium salicylate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000482	0.00103	CcSEcCtD
Magnesium salicylate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000481	0.00103	CcSEcCtD
Magnesium salicylate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000479	0.00102	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.00102	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.00101	CcSEcCtD
Magnesium salicylate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000471	0.001	CcSEcCtD
Magnesium salicylate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000463	0.000987	CcSEcCtD
Magnesium salicylate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000454	0.000968	CcSEcCtD
Magnesium salicylate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000445	0.000949	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000948	CcSEcCtD
Magnesium salicylate—Rash—Etoposide—peripheral nervous system neoplasm	0.000442	0.000941	CcSEcCtD
Magnesium salicylate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000441	0.00094	CcSEcCtD
Magnesium salicylate—Headache—Etoposide—peripheral nervous system neoplasm	0.000439	0.000935	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000436	0.000929	CcSEcCtD
Magnesium salicylate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000416	0.000887	CcSEcCtD
Magnesium salicylate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000844	CcSEcCtD
Magnesium salicylate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000837	CcSEcCtD
Magnesium salicylate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000823	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000809	CcSEcCtD
Magnesium salicylate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000797	CcSEcCtD
Magnesium salicylate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000367	0.000782	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000366	0.000781	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000774	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000762	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000748	CcSEcCtD
Magnesium salicylate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000744	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000738	CcSEcCtD
Magnesium salicylate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000346	0.000736	CcSEcCtD
Magnesium salicylate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000727	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000723	CcSEcCtD
Magnesium salicylate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000715	CcSEcCtD
Magnesium salicylate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000715	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000689	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000688	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.000681	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000673	CcSEcCtD
Magnesium salicylate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000665	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000662	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000662	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000638	CcSEcCtD
Magnesium salicylate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000615	CcSEcCtD
Magnesium salicylate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000592	CcSEcCtD
Magnesium salicylate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000572	CcSEcCtD
Magnesium salicylate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000553	CcSEcCtD
Magnesium salicylate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000548	CcSEcCtD
Magnesium salicylate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000532	CcSEcCtD
Magnesium salicylate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00053	CcSEcCtD
Magnesium salicylate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000527	CcSEcCtD
Magnesium salicylate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000527	CcSEcCtD
Magnesium salicylate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000524	CcSEcCtD
Magnesium salicylate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000512	CcSEcCtD
Magnesium salicylate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000497	CcSEcCtD
Magnesium salicylate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000492	CcSEcCtD
Magnesium salicylate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000488	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000488	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000485	CcSEcCtD
Magnesium salicylate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.00046	CcSEcCtD
